Skip to main content

Mark Wilterding

Head of Investor Relations

Edwards Lifesciences Corp (EW)

Equibles does not estimate personal net worth.

Get an email with a short summary when Edwards Lifesciences Corp publishes a filing, an earnings call transcript or a press release.

Get EW alerts

About Mark Wilterding

Mark Wilterding is recorded as Head of Investor Relations at Edwards Lifesciences Corp (EW). Mark Wilterding has spoken on 18 earnings calls across 1 company, most recently for Edwards Lifesciences Corp on October 24, 2024. Edwards Lifesciences Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Edwards Lifesciences Corp includes Bernard Zovighian (CEO and Board Member), Mr. Mussallem (CEO), Mr. Zovighian (CEO) and 7 others.

Mark Wilterding on recent calls

“With me on today's call is our CEO, Bernard Zovighian, and our CFO, Scott Ullem. Also joining us for the Q&A portion of the call will be Larry Wood, our Group President of TAVR and Surgical Structural Heart, Daveen Chopra, our Global Leader of TMTT, and Wayne Markowitz, our Global Leader of Surgical Structural Heart.”
Head of Investor Relations, Edwards Lifesciences Corp Q3 FY2024 Earnings Call ·
“With me on today's call is our CEO, Bernard Zovighian; and our CFO, Scott Ullem.”
Head of Investor Relations, Edwards Lifesciences Corp Q2 FY2024 Earnings Call ·
“With me on today's call is our CEO, Bernard Zovighian, and our CFO, Scott Ullem.”
Head of Investor Relations, Edwards Lifesciences Corp Q1 FY2024 Earnings Call ·
“With me on today's call is our CEO, Bernard Zovighian; and our CFO, Scott Ullem.”
Head of Investor Relations, Edwards Lifesciences Corp Q4 FY2023 Earnings Call ·
“We are coming to you live from San Francisco at the 35th Annual TCT Conference. With me on today's call is our CEO, Bernard Zovighian, and our CFO, Scott Ullem.”
Head of Investor Relations, Edwards Lifesciences Corp Q3 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at Edwards Lifesciences Corp

Recent activity

Show 6 earlier activities